AbbVie Inc (ABBV)

ABBV (NYSE:Drugs) EQUITY
$59.43
pos +0.00
+0.00%
Today's Range: 58.95 - 60.00 | ABBV Avg Daily Volume: 7,518,500
Last Update: 12/02/16 - 4:03 PM EST
Volume: 0
YTD Performance: 0.32%
Open: $0.00
Previous Close: $59.16
52 Week Range: $50.71 - $68.12
Oustanding Shares: 1,625,099,012
Market Cap: 96,140,857,550
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 5 6
Moderate Buy 1 1 1 1
Hold 9 8 7 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.53 2.40 2.36 2.21
Latest Dividend: 0.64
Latest Dividend Yield: 4.33%
Dividend Ex-Date: 01/11/17
Price Earnings Ratio: 15.99
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
15.99 16.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.31% 2.96% 22.81%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.50 0.20 0.07
Net Income 190.00 0.00 -0.01
EPS 184.50 -0.10 -0.02
Earnings for ABBV:
EBITDA 8.37B
Revenue 22.86B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.20 $1.26 $4.82 $5.45
Number of Analysts 9 3 11 12
High Estimate $1.26 $1.28 $4.85 $5.53
Low Estimate $1.17 $1.21 $4.80 $5.28
Prior Year $1.13 $1.15 $4.29 $4.82
Growth Rate (Year over Year) 5.90% 9.28% 12.38% 13.08%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Guy Ortmann

 | Nov 14, 2016 | 12:27 PM EST
What stocks have changed direction in the past week.
RMPIA
By

David Peltier

 | Nov 10, 2016 | 1:30 PM EST
Check out these 15 stocks that boast solid dividend yields and are growing earnings.
RMPIA
By

Jim Cramer

 | Nov 1, 2016 | 4:09 PM EDT
Today there was a virtual vacuum of good news in the stock market.
By

Jim Cramer

 | Nov 1, 2016 | 7:01 AM EDT
We have to ask: where is the cash flow to pay off the debt, if any important prices are rolled back?

bearishAbbvie downgraded at Credit Suisse

Oct 31, 2016 | 8:19 AM EDT
ABBV was downgraded from Outperform to Neutral, Credit Suisse said. $60 price target. Humira longevity concerns are increasing.
RMPIA
By

Jim Cramer

 | Oct 28, 2016 | 12:00 PM EDT
McKesson's disappointing earnings report ignited a selloff in health care stocks, and Jim Cramer says investors are questioning the sector's future.
RMPIA
By

Guy Ortmann

 | Oct 17, 2016 | 12:15 PM EDT
Technology stocks dominate the bearish ledger this week.
By

Tim Hesselsweet

 | Oct 17, 2016 | 12:00 PM EDT
With Clinton apparently headed for victory, worries about her being a threat to health-care stocks have peaked.
RMPIA
By

David Katz

 | Oct 5, 2016 | 7:00 AM EDT
The dreck of the first half will be the gems of year end.
RMPIA
By

Bret Jensen

 | Sep 13, 2016 | 12:00 PM EDT
These stocks look good as seasonal volatility sets in.
Shares of UPS are looking a bit vulnerable.  The stock's post election rally has stal...
As a technician, I look for trends and patterns that repeat over and over again. Some are ...
Market looks like it will open ever so slightly down after an inline Jobs report that saw ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.